Singh Umesh, Bernstein Jonathan A, Haar Lauren, Luther Kristin, Jones Walter K
Division of Allergy Section, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Am J Rhinol Allergy. 2014 May-Jun;28(3):215-24. doi: 10.2500/ajra.2014.28.4059.
Capsaicin, a prototypic transient receptor potential vanilloid 1 (TRPV1) agonist, has been shown to be more clinically effective in the treatment of nonallergic rhinitis (NAR) compared with other rhinitis subtypes. Azelastine has also been found to be clinically effective in the treatment of NAR but its mechanism(s) of action is still poorly elucidated. This study was designed to determine, using in vitro cell lines, whether topical therapies including azelastine have activity on TRPV1 ion channels similar to capsaicin.
The effects of capsaicin (1 μM), azelastine (30 μM), bepotastine (10 μM), olopatadine (10 μM), and fluticasone (200 μM) on TRPV1 channels using mice neuronal cells (Cath.a), as surrogates for submucosal sensory neurons, and human nasal epithelial cells (hNEC) were determined and compared. For azelastine, bepotastine, and capsaicin, which elicited an agonist effect on TRPV1, live cell [Ca(2+)] signaling in Cath.a cells and hNECs expressing TRPV1 were performed in the absence and presence of capsazepine at 10 μM (a TRPV1 antagonist) or using wild-type mouse embryonic fibroblasts (wtMEFs) that express TRPV1 ion channels and TRPV1 homozygous null mutant (TRPV1-/-) knockout MEF cells as controls to establish TRPV1 channel selectivity. As azelastine has previously been found clinically effective in NAR, additional experiments were performed to determine its ability to desensitize TRPV1 ion channels and its effect on regulating intracellular calcium homeostasis.
Cath.a cells treated with azelastine, bepotastine, or capsaicin showed a significant increase in TRPV1-dependant (Ca(2+)) specific cytosolic fluorescence. Continuous treatment with azelastine or capsaicin resulted in desensitization of TRPV1 channels. In hNECs, azelastine stimulation resulted in Ca(2+) shifts from the cytosol to mitochondria and overexpression of hematopoietic cell-specific Lyn substrate 1-associated protein X1, which may thus be effective in cytosolic Ca(2+) homeostasis.
Azelastine, similar to capsaicin, exhibits direct activity on TRPV1 ion channels that may represent a novel mechanistic pathway explaining its clinical efficacy in NAR.
辣椒素作为一种典型的瞬时受体电位香草酸受体1(TRPV1)激动剂,已被证明与其他鼻炎亚型相比,在治疗非过敏性鼻炎(NAR)方面具有更高的临床疗效。氮卓斯汀也被发现对NAR的治疗具有临床疗效,但其作用机制仍不清楚。本研究旨在利用体外细胞系确定包括氮卓斯汀在内的局部治疗对TRPV1离子通道是否具有与辣椒素相似的活性。
使用小鼠神经元细胞(Cath.a)作为黏膜下感觉神经元的替代物,以及人鼻上皮细胞(hNEC),测定并比较辣椒素(1 μM)、氮卓斯汀(30 μM)、贝波司汀(10 μM)、奥洛他定(10 μM)和氟替卡松(200 μM)对TRPV1通道的影响。对于对TRPV1产生激动作用的氮卓斯汀、贝波司汀和辣椒素,在存在或不存在10 μM辣椒素(一种TRPV1拮抗剂)的情况下,对表达TRPV1的Cath.a细胞和hNEC进行活细胞[Ca(2+)]信号传导,或者使用表达TRPV1离子通道的野生型小鼠胚胎成纤维细胞(wtMEF)和TRPV1纯合缺失突变(TRPV1-/-)敲除MEF细胞作为对照,以确定TRPV1通道的选择性。由于氮卓斯汀此前已被发现对NAR具有临床疗效,因此进行了额外的实验,以确定其使TRPV1离子通道脱敏的能力及其对调节细胞内钙稳态的影响。
用氮卓斯汀、贝波司汀或辣椒素处理的Cath.a细胞显示,TRPV1依赖性(Ca(2+))特异性胞质荧光显著增加。用氮卓斯汀或辣椒素持续处理导致TRPV1通道脱敏。在hNEC中,氮卓斯汀刺激导致Ca(2+)从细胞质转移到线粒体,并导致造血细胞特异性Lyn底物1相关蛋白X1的过表达,因此可能对细胞质Ca(2+)稳态有效。
与辣椒素类似,氮卓斯汀对TRPV1离子通道具有直接活性,这可能代表了一种新的机制途径,解释了其在NAR中的临床疗效。